I found Jeane first as an author but then as a fellow cancer patient. I'm in awe of her fundraising campaign. I'm supporting Canadian Cancer Society! do.nr/d6w8s547 via DonorDrive

New #JITC review: Genetic drivers of tumor microenvironment and immunotherapy resistance in non-small cell lung cancer: the role of KEAP1, SMARCA4, and PTEN mutations bit.ly/3Hzc6yO

I’m a scientist. I trust decades of research, not conspiracy threads. I know mRNA technology is one of the most powerful medical tools we’ve ever created. So yes - I stand with mRNA. Because ignorance kills. And science saves lives.

New Research: Chemokines: humble yet mighty players in the tumour microenvironment frontiersin.org/articles/10.33… #FrontiersIn #Immunology

Today we observe #WorldBreastCancerResearchDay, a time to heighten awareness for the critical research being conducted. This day is meant to show how far research has come, and how far it still needs to go.

Such great news: Another cohort of family-doctors-to-be starting the program at Queen's Health Sciences Lakeridge Health. This is the 3rd cohort of the very popular MD-FM program. Won’t be long before some lucky Ontario communities welcome these new family doctors!

Six Research@Queen's University projects awarded $5.8M from CIHR to advance cancer care, chronic pain, gene therapy, Indigenous health, and primary care. healthsci.queensu.ca/stories/news-a…

Just published in nature, Clements et al. reveal that axonal injury is a key driver of early GBM progression, overturning the assumption that early GBM growth is purely tumor-cell intrinsic and showing neurons profoundly shape GBM biology throughout their life cyle